Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,935 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improved multilineage response of hematopoiesis in patients with myelodysplastic syndromes to a combination therapy with all-trans-retinoic acid, granulocyte colony-stimulating factor, erythropoietin and alpha-tocopherol.
Ganser A, Maurer A, Contzen C, Seipelt G, Ottmann OG, Schadeck-Gressel C, Kolbe K, Haas R, Zander C, Reutzel R, Hoelzer D. Ganser A, et al. Among authors: haas r. Ann Hematol. 1996 Apr;72(4):237-44. doi: 10.1007/s002770050166. Ann Hematol. 1996. PMID: 8624378 Clinical Trial.
[Aspects of internal medicine].
Haas R, Germing U. Haas R, et al. Radiologe. 2000 Jun;40(6):495-9. doi: 10.1007/s001170050746. Radiologe. 2000. PMID: 10929385 German.
Favourable response to antithymocyte or antilymphocyte globulin in low-risk myelodysplastic syndrome patients with a 'non-clonal' pattern of X-chromosome inactivation in bone marrow cells.
Aivado M, Rong A, Stadler M, Germing U, Giagounidis A, Strupp C, Novotny J, Josten KM, Kobbe G, Hildebrandt B, Gattermann N, Aul C, Haas R, Ganser A. Aivado M, et al. Among authors: haas r. Eur J Haematol. 2002 Apr;68(4):210-6. doi: 10.1034/j.1600-0609.2002.01625.x. Eur J Haematol. 2002. PMID: 12071936 Clinical Trial.
Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioning.
Kobbe G, Schneider P, Aivado M, Zohren F, Schubert D, Fenk R, Neumann F, Kronenwett R, Pape H, Rong A, Royer-Pokora B, Hildebrandt B, Germing U, Gattermann N, Heyll A, Haas R. Kobbe G, et al. Among authors: haas r. Exp Hematol. 2002 Nov;30(11):1346-53. doi: 10.1016/s0301-472x(02)00923-2. Exp Hematol. 2002. PMID: 12423689 Free article.
1,935 results